Works by Kasperkiewicz, M.

Results: 22

Serological response to SARS‐CoV‐2 vaccination in patients with immunobullous diseases.

Published in:

JEADV Clinical Practice, 2024, v. 3, n. 5, p. 1686, doi. 10.1002/jvc2.490

By:

Levian, B.;
Tukaj, S.;
Woodley, D. T.;
Kasperkiewicz, M.

Publication type:

Article

Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.

Published in:

Clinical & Experimental Dermatology, 2010, v. 35, n. 6, p. 614, doi. 10.1111/j.1365-2230.2009.03731.x

By:

Kasperkiewicz, M.;
Hoppe, U.;
Zillikens, D.;
Schmidt, E.

Publication type:

Article

Subacute cutaneous lupus erythematosus associated with terbinafine.

Published in:

2009

By:

Kasperkiewicz, M.;
Anemüller, W.;
Angelova-Fischer, I.;
Rose, C.;
Zillikens, D.;
Fischer, T. W.

Publication type:

Letter

Differing features of pemphigus in skin of colour versus white skin: A broad‐scale cohort study.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 1, p. e54, doi. 10.1111/jdv.20094

By:

Kasperkiewicz, M.;
Elbuluk, N.;
Ngo, B. T.;
Kridin, K.;
Ludwig, R. J.

Publication type:

Article

Role of the International Pemphigus and Pemphigoid Foundation during the COVID‐19 pandemic.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 9, p. e664, doi. 10.1111/jdv.18180

By:

Kasperkiewicz, M.;
Strong, R.;
Yale, M.;
Dunn, P.;
Woodley, D.T.

Publication type:

Article

Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID‐19.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 7, p. e498, doi. 10.1111/jdv.18030

By:

Kasperkiewicz, M.;
Woodley, D.T.

Publication type:

Article

COVID‐19 pandemic and autoimmune bullous diseases: a cross‐sectional study of the International Pemphigus and Pemphigoid Foundation.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 7, p. e418, doi. 10.1111/jdv.17228

By:

Kasperkiewicz, M.;
Yale, M.;
Strong, R.;
Zillikens, D.;
Woodley, D.T.;
Recke, A.

Publication type:

Article

Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 7, p. e412, doi. 10.1111/jdv.17207

By:

Kasperkiewicz, M.;
Schmidt, E.;
Amagai, M.;
Fairley, J.A.;
Joly, P.;
Murrell, D.F.;
Payne, A.S.;
Yale, M.L.;
Zillikens, D.;
Woodley, D.T.

Publication type:

Article

Expression of PD‐1 and Tim‐3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 2, p. 486, doi. 10.1111/jdv.16780

By:

Ernst, N.;
Friedrich, M.;
Bieber, K.;
Kasperkiewicz, M.;
Gross, N.;
Sadik, C.D.;
Zillikens, D.;
Schmidt, E.;
Ludwig, R.J.;
Hartmann, K.

Publication type:

Article

Expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 7, p. e302, doi. 10.1111/jdv.16525

By:

Kasperkiewicz, M.;
Schmidt, E.;
Fairley, J.A.;
Joly, P.;
Payne, A.S.;
Yale, M.L.;
Zillikens, D.;
Woodley, D.T.

Publication type:

Article

Anti-Laminin-332-Schleimhautpemphigoid mit irreversiblem okulärem und tracheobronchialem Befall: Verspätete Diagnosestellung einer schweren bullösen Autoimmunerkrankung.

Published in:

Der Hautarzt, 2019, v. 70, n. 5, p. 367, doi. 10.1007/s00105-019-4402-z

By:

Syring, F. M.;
Zillikens, D.;
Schmidt, E.;
Kasperkiewicz, M.

Publication type:

Article

Anti-p200/Laminin-γ1-Pemphigoid in Kombination mit einem BP180 NC16A/4575-positiven Schleimhautpemphigoid.

Published in:

Der Hautarzt, 2015, v. 66, n. 1, p. 60, doi. 10.1007/s00105-014-3529-1

By:

Kaune, K.M.;
Kasperkiewicz, M.;
Tams, D.;
Bergmann, M.;
Zutt, M.

Publication type:

Article

Bullöses Pemphigoid.

Published in:

Der Hautarzt, 2013, v. 64, n. 12, p. 931, doi. 10.1007/s00105-013-2599-9

By:

Schulze, F.;
Kasperkiewicz, M.;
Zillikens, D.;
Schmidt, E.

Publication type:

Article

Bullöse Autoimmunkrankheiten bei Kindern.

Published in:

Der Hautarzt, 2013, v. 64, n. 6, p. 447, doi. 10.1007/s00105-013-2536-y

By:

Sárdy, M.;
Kasperkiewicz, M.

Publication type:

Article

Rituximab (anti-CD20) zur Behandlung von bullösen Autoimmundermatosen.

Published in:

Der Hautarzt, 2007, v. 58, n. 2, p. 115, doi. 10.1007/s00105-007-1284-2

By:

Kasperkiewicz, M.;
Zillikens, D.

Publication type:

Article

Influence of cigarette smoking on pemphigus - a systematic review and pooled analysis of the literature.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 8, p. 1256, doi. 10.1111/jdv.14886

By:

Lai, O.;
Recke, A.;
Zillikens, D.;
Kasperkiewicz, M.

Publication type:

Article

Calcitriol exerts anti-inflammatory effects in keratinocytes treated with autoantibodies from a patient with bullous pemphigoid.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2016, v. 30, n. 2, p. 288, doi. 10.1111/jdv.12929

By:

Tukaj, S.;
Grüner, D.;
Tukaj, C.;
Zillikens, D.;
Kasperkiewicz, M.

Publication type:

Article

COVID‐19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross‐sectional study of the International Pemphigus and Pemphigoid Foundation.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 4, p. 737, doi. 10.1111/bjd.20906

By:

Kasperkiewicz, M.;
Strong, R.;
Mead, K.;
Yale, M.;
Zillikens, D.;
Woodley, D.T.;
Recke, A.

Publication type:

Article

Clinical outcomes of patients with pemphigus treated by the same physicians in a public safety net healthcare system vs. a private healthcare system.

Published in:

British Journal of Dermatology, 2019, v. 181, n. 4, p. 850, doi. 10.1111/bjd.17983

By:

Kasperkiewicz, M.;
Lai, O.;
Recke, A.;
Betlachin, A.;
Ji, L.;
Groshen, S.;
Woodley, D.

Publication type:

Article

Vitamin D status in patients with bullous pemphigoid.

Published in:

British Journal of Dermatology, 2013, v. 168, n. 4, p. 873, doi. 10.1111/bjd.12037

By:

Tukaj, S.;
Schmidt, E.;
Recke, A.;
Ludwig, R.J.;
Zillikens, D.;
Tukaj, C.;
Kasperkiewicz, M.

Publication type:

Article

Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.

Published in:

British Journal of Dermatology, 2012, v. 166, n. 1, p. 154, doi. 10.1111/j.1365-2133.2011.10585.x

By:

Kasperkiewicz, M.;
Shimanovich, I.;
Meier, M.;
Schumacher, N.;
Westermann, L.;
Kramer, J.;
Zillikens, D.;
Schmidt, E.

Publication type:

Article

Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.

Published in:

British Journal of Dermatology, 2010, v. 162, n. 5, p. 1064, doi. 10.1111/j.1365-2133.2010.09680.x

By:

Kasperkiewicz, M.;
Hirose, M.;
Recke, A.;
Schmidt, E.;
Zillikens, D.;
Ludwig, R.J.

Publication type:

Article